The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.
about
Bacterial infections in cirrhosis: A critical review and practical guidanceBacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study.Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.The relevance of intestinal dysbiosis in liver transplant candidates.Bloodstream infections in patients with liver cirrhosis.Novel prevention strategies for bacterial infections in cirrhosis.Safety of medication options for treating pediatric esophagitis.Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.The impact of proton pump inhibitor therapy on patients with liver disease.The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.Proton pump inhibitor prescription abuse and sepsis in cirrhosis.Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus.The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis.Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.We have had a gutful: The need for deprescribing proton pump inhibitors.Safe use of proton pump inhibitors in patients with cirrhosis.The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis
P2860
Q26766663-0C409B21-277F-4222-A819-386E763EAD86Q33822986-B53C707B-A627-49AD-A355-BEA4494935B6Q34519283-5BE4262C-15DC-4260-8E13-0C62CAF20353Q34647371-5F9E4DD3-F2BD-4FFE-9007-E72E8BA76CB1Q35569791-CEBC26C8-ABB9-4E92-B21F-88C3B0108CDCQ36913304-4D150DA2-2C07-45C5-9278-22FC0F092D58Q37183463-B9495572-2384-42DA-A4E6-991199BB6D03Q38442609-D861D4C8-685E-4A36-BBDD-EE6EB80EB27BQ38524991-342E9E1E-8BA3-41BF-ACEE-EF307D1687C6Q38865456-BC4575C3-B5D5-4B2E-9991-6C901B6093C2Q39256050-D6D34EED-DA10-42A5-94F1-33B35C780879Q40185640-B37CE327-CDBE-4B18-AA26-F500E1C0A6DEQ40800407-9461EADC-6442-4801-BCFD-5A69651FCA7FQ40933469-6B72EE58-45B1-433D-B1B7-077C7251E198Q42378987-6F3CF9A2-F6C0-4083-9493-E6CAA884013CQ44239223-D0E3C74D-1AC6-4ECA-97D5-CF4F1FF1FC24Q47283908-945972FB-0169-4256-AA25-1FA2C67C3524Q47998734-B0CC6134-1919-4F5D-ACD4-56330A03AD64Q55718075-A80FCDA9-0D3E-4CC1-A476-DC42EFCC7F1DQ56925196-5244B0C8-EF84-4792-B5BF-2C3A5C93212E
P2860
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@ast
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@en
type
label
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@ast
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@en
prefLabel
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@ast
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@en
P2093
P2860
P50
P356
P1433
P1476
The chronic use of beta-blocke ...... erial infections in cirrhosis.
@en
P2093
Cristina Lucidi
Mario Venditti
Michela Giusto
Valerio Giannelli
Vincenza Di Gregorio
P2860
P304
P356
10.1111/LIV.12593
P577
2014-06-04T00:00:00Z